A plan to slash Food and Drug Administration drug review times is raising alarms at the public health agency that's been ...
When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did not receive support from any Republican senators. In ...
A bill bolstering a federal drug discount program that conservative critics have warned is a backdoor effort to subsidize transgender treatments for minors passed in the Oklahoma Senate last week, ...
Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on drugs cleared under a new plan to slash FDA drug review times.
On January 15, 2025, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) posted Advisory Opinion 25-01, a favorable opinion analyzing a pharmaceutical manufacturer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results